Butaclamol

chembox new
ImageFile=Butaclamol.svg
ImageSize=
IUPACName=3-(1,1-dimethylethyl)-2,3,4,4"a",8,9, 13"b",14-octahydro-1"H"-benzo [6,7] cyclohepta [1,2,3-"de"] pyrido [2,1-"a"] isoquinolin-3-ol
OtherNames=
Section1=Chembox Identifiers
CASNo=
PubChem=37461
SMILES=CC(C)(C)C1(CCN2CC3C4=CC=CC=C4CCC5=C3C(=CC=C5)C2C1)O

Section2=Chembox Properties
Formula=C25H31NO
MolarMass=361.52 g/mol
Appearance=
Density=
MeltingPt=
BoilingPt=
Solubility=

Section3=Chembox Hazards
MainHazards=
FlashPt=
Autoignition=

Butaclamol (INN) is an antipsychotic. It acts as a dopamine antagonist.


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Clozapine — Not to be confused with clonazepam or Klonopin. Clozapine Systematic (IUPAC) name …   Wikipedia

  • Chlorpromazine — Systematic (IUPAC) name …   Wikipedia

  • Olanzapine — Systematic (IUPAC) name 2 methyl 4 (4 methyl …   Wikipedia

  • Loxapine — Systematic (IUPAC) name 2 Chloro 11 (4 methylpiperazin 1 yl)dibenzo[b,f][1,4]oxazepine Clinical data AHFS/Drugs.com …   Wikipedia

  • Amoxapine — Systematic (IUPAC) name 2 Chloro 11 (piperazin 1 yl)dibenzo[b,f][1,4]oxazepine Clinical data Trade names Asendin …   Wikipedia

  • Chlorprothixene — Systematic (IUPAC) name (Z) 3 (2 chlorothioxanthen 9 ylidene) N, N dimethyl propan 1 amine Clinical data …   Wikipedia

  • Flupentixol — Systematic (IUPAC) name (EZ) 2 [4 [3 [2 (trifluoromethyl)thioxanthen 9 ylidene]propyl]piperazin 1 yl]ethanol Clinical data A …   Wikipedia

  • Mesoridazine — Systematic (IUPAC) name 10 {2 [(RS)1 Methylpiperidin 2 yl]ethyl} 2 meth …   Wikipedia

  • Metitepine — Systematic (IUPAC) name 1 methyl 4 (8 methylsulfanyl 5,6 dihydrobenzo[b][1]benzothiepin 6 yl)piperazine Clinical data Pregnancy cat …   Wikipedia

  • Cyamemazine — Systematic (IUPAC) name 10 (3 dimethylamino 2 methyl propyl)phenothiazine 2 carbonitrile Clinical data AHFS/Drugs.com …   Wikipedia


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.